TI
OSIR

Turner Investments’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Turner Investments’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-91,500
Closed -$1.78M – 334
2015
Q2 		$1.78M Buy
91,500
+90,000
+6,000% +$1.59M 0.33% 106
2015
Q1 		$26K Buy
+1,500
New +$25.2K ﹤0.01% 327

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Turner Investments's OSIR Position: Q3 2015 in Review

Turner Investments sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q3 2015, closing a stake of 91,500 shares — an estimated $1.78M sold.

Turner Investments first reported a position in OSIR in Q1 2015 and held it in 2 quarters. The position peaked at $1.78M in Q2 2015. 92 funds tracked by Wall St. Rank hold OSIR as of Q3 2015.

  • Turner Investments reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Turner Investments sold 91,500 Osiris Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $1.78M.
  • Turner Investments first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2015 and held it in 2 quarters.
  • Turner Investments's Osiris Therapeutics, Inc. Common Stock position peaked at $1.78M in Q2 2015.
  • 92 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q3 2015.

Based on Turner Investments's 13F filing for Q3 2015, filed 12 Nov 2015.